DrugPatentWatch Database Preview
AMPHADASE Drug Profile
» See Plans and Pricing
Summary for Tradename: AMPHADASE
| Patents: | 493 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Drug Prices: | Drug price information for AMPHADASE |
| Recent Clinical Trials: | See clinical trials for AMPHADASE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for AMPHADASE |
Recent Clinical Trials for AMPHADASE
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Amphastar Pharmaceuticals, Inc. | Phase 2 |
Recent Litigation for AMPHADASE
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC | 2018-12-19 |
| KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC | 2018-11-08 |
| Halozyme, Inc. v. Lee | 2016-12-19 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| 2017-05-30 | |
| 2017-01-31 |
Patent Text Search: US Patents for AMPHADASE
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | Oxyrane UK Limited (Manchester, GB) | 2030-09-29 | RX | search | |
| Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | RX | search | |
| Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | Oxyrane UK Limited (Manchester, GB) VIB vzw (Ghent, BE) Universiteit Gent (Ghent, BE) | 2027-04-03 | RX | search | |
| Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V. (DE) Asklepios Kliniken Verwaltungsgesellschaft mbH (DE) | 2033-12-05 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for AMPHADASE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20100134671 | Start Trial |
| European Patent Office | 2403436 | Start Trial |
| Canada | 2323199 | Start Trial |
| Portugal | 1117769 | Start Trial |
| Germany | 2915309 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for AMPHADASE
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 300822 | Netherlands | Start Trial | PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326 |
| 132016000025345 | Italy | Start Trial | PRODUCT NAME: TRASTUZUMAB PER USO SOTTOCUTANEO(HERCEPTIN); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/00/145/002, 20130828 |
| 300753 | Netherlands | Start Trial | PRODUCT NAME: TRASTUZUMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826 |
| C02475353/01 | Switzerland | Start Trial | PRODUCT NAME: RITUXIMAB; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65813 28.06.2016 |
| 2017C/063 | Belgium | Start Trial | PRODUCT NAME: SEL DE SODIUM D'ACIDE DESOXYCHOLIQUE; AUTHORISATION NUMBER AND DATE: SE/H/1547/01/DC 20170612 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
